N.sup.6 -Substituted diarylalkyladenosines and pharmaceutically acceptable acid addition salts having highly desirable central nervous system and cardiovascular properties, processes for their manufacture and pharmaceutical compositions and methods for using said compounds and compositions are described.
N6-substituted diarylalkyl adenosines, processes for their production and pharmaceutical compositions comprising the same
申请人:WARNER-LAMBERT COMPANY
公开号:EP0139358A2
公开(公告)日:1985-05-02
N6 -Substittuted diarylalkyladenosines of the formula:
are disclosed. Processes for their manufacture and pharmaceutical compositions containing the same are also disclosed. The compounds have highly desirable central- nervous system and cardio-vascular properties.
N6- substituted diarylalkyl adenosines, processes for their production and pharmaceutical compositions comprising the same
申请人:WARNER-LAMBERT COMPANY
公开号:EP0251339A2
公开(公告)日:1988-01-07
N⁶-Substituted diarylalkyladenosines of the formula:
are disclosed. Processes for their manufacture and pharmaceutical compositions containing the same are also disclosed. The compounds have highly desirable central-nervous system and cardio-vascular properties.